Exact Mass: 410.0671

Exact Mass Matches: 410.0671

Found 23 metabolites which its exact mass value is equals to given mass value 410.0671, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tanomastat

Tanomastat

C23H19ClO3S (410.0743)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

7,11,12-Triacetoxycoumestan

5,14-Bis(acetyloxy)-9-oxo-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11,13,15-heptaen-13-yl acetic acid

C21H14O9 (410.0638)


Animal growth stimulan

   

Tanomastat

4-{4-chloro-[1,1-biphenyl]-4-yl}-4-oxo-2-[(phenylsulphanyl)methyl]butanoic acid

C23H19ClO3S (410.0743)


   
   

5-hydroxy-6,7,4-trimethoxyflavanone-5-sulfate

5-hydroxy-6,7,4-trimethoxyflavanone-5-sulfate

C18H18O9S (410.0671)


   

aspergillusether A

aspergillusether A

C20H20Cl2O5 (410.0688)


   

oxalicumone D

oxalicumone D

C18H18O9S (410.0671)


   

6-Methoxycomaparvin sulphate

6-Methoxycomaparvin sulphate

C18H18O9S (410.0671)


   

Stimol 410

5,14-bis(acetyloxy)-9-oxo-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11,13,15-heptaen-13-yl acetate

C21H14O9 (410.0638)


   
   

1-(4-BroMophenyl)-1,2,2-triphenylethylene

1-(4-BroMophenyl)-1,2,2-triphenylethylene

C26H19Br (410.067)


   

(3-BROMOPHENOXY)(TERT-BUTYL)DIPHENYLSILANE

(3-BROMOPHENOXY)(TERT-BUTYL)DIPHENYLSILANE

C22H23BrOSi (410.0701)


   

N-Desmethyl Zopiclone Hydrochloride

N-Desmethyl Zopiclone Hydrochloride

C16H16Cl2N6O3 (410.0661)


   

4-[4-(4-Chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid

4-[4-(4-Chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid

C23H19ClO3S (410.0743)


   

ethyl 2-chloro-5-[5-[(E)-(5-cyano-4-methyl-2,6-dioxopyridin-3-ylidene)methyl]furan-2-yl]benzoate

ethyl 2-chloro-5-[5-[(E)-(5-cyano-4-methyl-2,6-dioxopyridin-3-ylidene)methyl]furan-2-yl]benzoate

C21H15ClN2O5 (410.0669)


   

7,11,12-Triacetoxycoumestan

7,11,12-Triacetoxycoumestan

C21H14O9 (410.0638)


   

SIRT2/6-IN-1

SIRT2/6-IN-1

C19H14N4O5S (410.0685)


SIRT2/6-IN-1 (Compound 5) is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. SIRT2/6-IN-1 increases H3K9 acetylation, increases glucose uptake and reduces TNF-α secretion in cells[1].

   

6,7,12,16,17-pentahydroxy-12-(2-oxopropyl)-3,20-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(13),2(10),4,6,8,14,16,18-octaen-11-one

6,7,12,16,17-pentahydroxy-12-(2-oxopropyl)-3,20-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]icosa-1(13),2(10),4,6,8,14,16,18-octaen-11-one

C21H14O9 (410.0638)


   

methyl 3-chloro-2-[2,4-dimethoxy-6-(methoxycarbonyl)phenoxy]-6-hydroxy-4-methylbenzoate

methyl 3-chloro-2-[2,4-dimethoxy-6-(methoxycarbonyl)phenoxy]-6-hydroxy-4-methylbenzoate

C19H19ClO8 (410.0768)


   

(2r)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid

(2r)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid

C18H18O9S (410.0671)


   

2,4-dihydroxy-4-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}-5-methoxy-5-oxopentanoic acid

2,4-dihydroxy-4-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}-5-methoxy-5-oxopentanoic acid

C18H18O9S (410.0671)


   

{5-hydroxy-6,10-dimethoxy-4-oxo-2-propylbenzo[h]chromen-8-yl}oxidanesulfonic acid

{5-hydroxy-6,10-dimethoxy-4-oxo-2-propylbenzo[h]chromen-8-yl}oxidanesulfonic acid

C18H18O9S (410.0671)


   

(2r,4s)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid

(2r,4s)-2,4-dihydroxy-4-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]-5-methoxy-5-oxopentanoic acid

C18H18O9S (410.0671)